LatinNews Daily - 29 May 2026

*Mexico’s President Claudia Sheinbaum has highlighted investment of more than M$21bn (US$1.2bn) announced by the pharmaceutical industry to increase domestic production of medicines, vaccines, medical devices, and healthcare supplies. Sheinbaum said the investment was being made as part of the broader Plan México, which aims to boost domestic industry and supply chains. The health minister, David Kershenobich, said the initiative would strengthen Mexico’s pharmaceutical industry, supporting self-sufficiency in medicine production. Sheinbaum stated that the objective of Plan México was “to produce more in Mexico than we consume in Mexico and also to allow us to export to other countries, not just the US”. Pharmaceutical companies including US firms Abbott and Bristol Myers Squibb, Mexico’s Grupo Neolpharma, Laboratorios Kener, Laboratorios Liomont, and Vazol Farma, France’s Sanofi and Opella, and Germany’s Bayer presented their investment plans, ranging from the production of pharmaceutical materials, medicines, and vaccines, to the manufacturing of medical devices and diagnostic equipment.

End of preview - This article contains approximately 158 words.

Subscribers: Log in now to read the full article

Not a Subscriber?

Choose from one of the following options

• Subscribe
• Sign up for a one-time, 14-day trial